BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krepel Volsky S, Shalitin S, Fridman E, Yackobovitch-Gavan M, Lazar L, Bello R, Oron T, Tenenbaum A, de Vries L, Lebenthal Y. Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A single-center experience. World J Diabetes 2021; 12(1): 56-68 [PMID: 33520108 DOI: 10.4239/wjd.v12.i1.56]
URL: https://www.wjgnet.com/1948-9358/full/v12/i1/56.htm
Number Citing Articles
1
M. M. Shchurko, L. Ye. Lapovets, N. R. Demianchuk, V. M. Akimova. MODERN VIEWS ON THE PATHOGENESIS OF IMMUNE DYSFUNCTION AGAINST THE BACKGROUND OF THE METABOLIC SYNDROME IN ISCHEMIC HEART DISEASEUkrainian Journal of Laboratory Medicine 2023; 1(2): 60 doi: 10.62151/2786-9288.1.2.2023.08
2
Empar Lurbe. Blood Pressure Disorders in Diabetes MellitusUpdates in Hypertension and Cardiovascular Protection 2023; : 21 doi: 10.1007/978-3-031-13009-0_2
3
Yuan Kong, Qi-Qi Xing, Yu-Xuan Tian, Lin Li, Pan Yu, Lin-Guo Zhao, Dong-Dong Li. Design, synthesis, and biological activity of 9-O-cinnamoylberberines as novel lipid-lowering agentsNatural Product Research 2023; 37(20): 3452 doi: 10.1080/14786419.2022.2085697
4
Avivit Brener, Sandy Hamama, Hagar Interator, Asaf Ben Simon, Irina Laurian, Anna Dorfman, Efrat Chorna, Michal Yackobovitch‐Gavan, Asaf Oren, Ori Eyal, Yael Lebenthal. Sex differences in body composition in youth with type 1 diabetes and its predictive value in cardiovascular disease risk assessmentDiabetes/Metabolism Research and Reviews 2023; 39(1) doi: 10.1002/dmrr.3584
5
Joonsang Yoo, Jimin Jeon, Minyoul Baek, Sun Ok Song, Jinkwon Kim. Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort studyJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04691-6
6
Tamar Propper-Lewinsohn, Roni Elran-Barak, Michal Gillon-Keren, Michal Yackobovitch-Gavan, Alon Liberman, Moshe Phillip, Shlomit Shalitin. Disordered Eating Behaviors Among Adolescents and Young Adults with Type 1 Diabetes Treated with Insulin Pumps and Hybrid Closed-Loop SystemsDiabetes Technology & Therapeutics 2024; 26(4): 229 doi: 10.1089/dia.2023.0500